Wed, 05 Oct 2016 04:07:54 GMT
is used to treat a condition called paroxysmal supraventricular tachycardia (including a condition called Wolff-Parkinson-White syndrome). This is when the heart beats too rapidly. If left untreated, this condition can be life threatening.
Wed, 05 Oct 2016 00:10:34 GMT
Upper Township Rescue Squad looks for alternatives to costly EpiPen
- Shore News Today
26 Township Committee meeting that the squad has looked into using ampoules of epinephrine and syringes to inject it into a patient instead of the EpiPen. Mylan
, the pharmaceutical company that manufactures the EpiPen, recently raised the price to $600 ...
Tue, 04 Oct 2016 23:12:29 GMT
Mylan NV on Focus After Bearish Options Activity
- Frisco Fastball
In today's session Mylan
NV (MYL) recorded an unusually high (359) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the April, 2017 put, expecting serious MYL decrease. With 359 contracts traded and 4604 ...
Tue, 04 Oct 2016 22:07:42 GMT
Lowey Questions EpiPen Profit Figure Given to Congress by Mylan
pretax profit on the EpiPen is reportedly $160, however CEO Heather Bresch testified in front of Congress last week that the company makes a $100 profit on the product and did not mention the tax-related reduction, the Wall Street Journal reported.
Tue, 04 Oct 2016 21:56:20 GMT
Tue, 04 Oct 2016 19:08:00 GMT
Mylan, health officials pressed on EpiPen 'misclassifcation'
A U.S. Senator asked big drugmaker Mylan
and federal health officials Tuesday for information about a purported misclassification by the company of its anti-allergy EpiPen devices that would shortchange federal and state governments millions of dollars ...
Tue, 04 Oct 2016 19:04:40 GMT
House panel questions CEO
- Butler Eagle (subscription)
WASHINGTON — Leaders of the House Oversight Committee want EpiPen maker Mylan
to explain why the company's CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device. Mylan
CEO Heather ...
Tue, 04 Oct 2016 18:29:00 GMT
Mylan: Cheaper EpiPen May Not Come Until End of Year
NV's half-price version of its EpiPen allergy shot may not be available until the end of the year, the drugmaker said in an e-mail, potentially months after a timeline the company gave in August. The “authorized generic” version of EpiPen will be ...
Tue, 04 Oct 2016 18:28:09 GMT
Mylan Gets More Grief From Congress Over the EpiPen
Jason Chaffetz (R-Utah) and Elijah Cummings (D-Md.) wrote to Bresch, the committee learned that this number "omitted key tax assumptions," and that Mylan
likely paid a much lower tax rate. This puts the company's profit from EpiPens closer to $160 per ...
Tue, 04 Oct 2016 18:03:00 GMT
Current Mylan N.V. (NASDAQ:MYL) PT Means Stock Is Worth Almost $66
- Review FortuneMylan
N.V. (NASDAQ:MYL) down -7.24% for the past 5 days, is under coverage of 21 analysts who collectively assign a hold rating on stock. 13 of the brokerages firms have a buy or better rating; the 0 sells versus 0 underperforms. The 17 stock analysts ...